https://qilindo.com/wp-content/uploads/2021/10/Victory-Medical-FINAL-_.mp4
Victory Medical
Helping People Breathe Easy
Play Video
Play Video
Video
Presentation
One Pager
Favorites
Raising
$1,000,000
in exchange for
20%
Industry
Medical
Company Size
6-10
Patent
Provisional
Location
Oakton, Virginia, USA
Languages
English
Website URL
Overview
The Team
Problem & Solution
The Market
Low-cost, rapidly mass-produced compact ventilator
Designed for COVID-19 acute respiratory failure
Rapidly and easily deployable to mass casualty situations outside of traditional supply chains
The Vision
To rapidly produce low-cost ventilators to provide life-saving care to patients around the world.
The Product
Our low-cost ventilator is designed specifically for the high pressures required to treat COVID-19 lung failure but is usable by all ventilated patients. Our device would provide care for underserved communities around the world.
The device is pneumatically driven and can be operated in the absence of electricity. It is self-regulating when attached to an oxygen tank and durable enough to be used in the frontlines/regions far outside of the supply chain.
Overview
Low-cost, rapidly mass-produced compact ventilator
Designed for COVID-19 acute respiratory failure
Rapidly and easily deployable to mass casualty situations outside of traditional supply chains
The Vision
To rapidly produce low-cost ventilators to provide life-saving care to patients around the world.
The Product
Our low-cost ventilator is designed specifically for the high pressures required to treat COVID-19 lung failure but is usable by all ventilated patients. Our device would provide care for underserved communities around the world.
The device is pneumatically driven and can be operated in the absence of electricity. It is self-regulating when attached to an oxygen tank and durable enough to be used in the frontlines/regions far outside of the supply chain.
Problem & Solution
With the average ventilator costing 10,000-60,000 USD, they are cost prohibitive and act as a barrier to care. COVID-19 has shown the disparity in care between developed and developing nations.
Countries like India that do not have equitable resources when compared to the U.S. or many European nations are struggling to provide patients with ventilation care.
Our product would allow these nations, such as India, to have access to affordable ventilation solutions for patients with COVID-19 lung failure and any other ventilation needs.
Similarly, because the Victory-Vent is an order of magnitude cheaper than traditional ventilators it will serve as a device that is stockpileable in developed nations to act as a safeguard for another black swan event or mass casualty incident.
Furthermore, because our device needs no electricity to run it can be operated in homes, frontlines, and any non-traditional hospital setting that is on the extremities of the supply chain.
Please Sign In or Register to view this content.